Company intelligence / Profile preview

Tedec-Meiji Farma

Ownership: Private
Development stage: Other

Overview

Tedec-Meiji Farma operates as a Spanish pharmaceutical company specializing in the manufacture and sale of generic pharmaceuticals. It was established through Meiji Seika Pharma’s capital participation in 1991. The company focuses on anti-infective drugs, central nervous system disorder treatments, and lifestyle-related disease medications. It serves as a key European base for Meiji Seika Pharma’s international expansion strategy.

Therapeutic areas: Metabolic DisordersNeurologyInfectious Diseases
Modalities: Small moleculeGeneric drugs
Industry: Biotech

Partnerships

Part of the global network under Meiji Seika Pharma with collaborations in Europe and other regions for generic drug supply/manufacturing

Beyond the preview

Go deeper on Tedec-Meiji Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tedec-Meiji Farma.

Explore the full profile